
New Enterprise Associates
http://www.nea.com/Home/New Enterprise Associates is a venture capital firm based in Baltimore, MD. The firm has backed more than 160 companies that have gone public and invested in more than 230 companies that have been successfully merged or acquired. NEA focuses its investments in the information technology, healthcare, and energy technology industries. While NEA makes a majority of its investments in the United States, the firm invests around the world in China and India. The firm was founded in 1978.
View Older Stories View More Recent Stories
-
Form SC 13D/A Nkarta, Inc. Filed by: New Enterprise Associates 15, L.P.
-
Form SC 13D/A Robinhood Markets, Inc. Filed by: New Enterprise Associates 15, L.P.
-
Lumos Pharma, Inc. (LUMO) Enters Collaboration with Massachusetts General Hospital to Evaluate LUM-201
-
Form 4 Robinhood Markets, Inc. For: May 02 Filed by: New Enterprise Associates 17, L.P.
-
Form SC 13D/A IMARA Inc. Filed by: New Enterprise Associates 14, L.P.
-
Form SC 13D/A Trevi Therapeutics, Inc. Filed by: New Enterprise Associates 16, L.P.
-
Trevi Therapeutics (TRVI) Announces $55 Million Private Placement of Common Stock, Warrants
-
Form SC 13D Arcellx, Inc. Filed by: New Enterprise Associates 15, L.P.
-
Form SC 13G Tuya Inc. Filed by: New Enterprise Associates 14, L.P.
-
Form SC 13D/A Robinhood Markets, Inc. Filed by: New Enterprise Associates 15, L.P.
-
Form SC 13G/A Inozyme Pharma, Inc. Filed by: New Enterprise Associates 15, L.P.
-
Form SC 13G Coursera, Inc. Filed by: NEW ENTERPRISE ASSOCIATES 13 LP
-
Form SC 13G/A Cloudflare, Inc. Filed by: NEW ENTERPRISE ASSOCIATES 13 LP
-
Form 4 Robinhood Markets, Inc. For: Jan 28 Filed by: New Enterprise Associates 15, L.P.
-
Form SC 13D/A Bright Health Group Inc. Filed by: New Enterprise Associates 15, L.P.
-
Form SC 13D BuzzFeed, Inc. Filed by: NEW ENTERPRISE ASSOCIATES 13 LP
-
Form SC 13D/A IMARA Inc. Filed by: New Enterprise Associates 14, L.P.
-
Form SC 13D/A Metacrine, Inc. Filed by: New Enterprise Associates 16, L.P.
-
Form SC 13D/A LUMOS PHARMA, INC. Filed by: New Enterprise Associates 14, L.P.
-
Form SC 13D/A Liquidia Corp Filed by: New Enterprise Associates 12, Limited Partnership
-
Form SC 13D/A ARDELYX, INC. Filed by: New Enterprise Associates 12, Limited Partnership
-
Form SC 13D/A Bright Health Group Inc. Filed by: New Enterprise Associates 15, L.P.
-
ZeroFox to Acquire IDX, Will go Public Via Merger with L&F Acquisition Corp (LNFA)
-
Bright Health Group (BHG) Announces $750 Million Capital Raise to Support Continued Growth
-
Form SC 13D NEXTNAV INC. Filed by: New Enterprise Associates 14, L.P.
-
Regulus Therapeutics (RGLS) Announces 58.9M Share Private Placement at $0.36/sh
-
Form SC 13D/A Bloom Energy Corp Filed by: NEW ENTERPRISE ASSOCIATES 10 L P
-
Form SC 13D/A Casper Sleep Inc. Filed by: New Enterprise Associates 14, L.P.
-
Form SC 13G/A Annexon, Inc. Filed by: New Enterprise Associates 15, L.P.
-
Form SC 13D MINERVA SURGICAL INC Filed by: NEW ENTERPRISE ASSOCIATES 13 LP
-
Form 4 Robinhood Markets, Inc. For: Nov 10 Filed by: New Enterprise Associates 17, L.P.
-
Alcon (ALC) to Acquire Ivantis for $475M Upfront
-
Form SC 13D/A Trevi Therapeutics, Inc. Filed by: New Enterprise Associates 16, L.P.
-
Form 4 Robinhood Markets, Inc. For: Oct 27 Filed by: New Enterprise Associates 17, L.P.
-
Form SC 13D IonQ, Inc. Filed by: New Enterprise Associates 15, L.P.
-
Form 4 Trevi Therapeutics, Inc. For: Oct 18 Filed by: New Enterprise Associates 16, L.P.
-
Form SC 13D/A Desktop Metal, Inc. Filed by: New Enterprise Associates 15, L.P.
-
Form SC 13D Robinhood Markets, Inc. Filed by: New Enterprise Associates 15, L.P.
-
Form SC 13D Berkshire Grey, Inc. Filed by: New Enterprise Associates 15, L.P.
-
Form 4 Robinhood Markets, Inc. For: Aug 02 Filed by: New Enterprise Associates 17, L.P.
-
Metromile, Inc (MILE) Appoints John Butler and Sandra Clarke to its Board
-
Lumos Pharma, Inc. (LUMO) Announces Industry Veteran, David B. Karpf, MD, has Joined the Company as Chief Medical Officer
-
Lumos Pharma, Inc. (LUMO) Announces the Promotion of COO and Chief Scientific Officer, John McKew, PhD, to President
-
Form 3 Robinhood Markets, Inc. For: Jul 29 Filed by: New Enterprise Associates 17, L.P.
-
Form SC 13D Bright Health Group Inc. Filed by: New Enterprise Associates 17, L.P.
-
Lumos Pharma (LUMO) issues new guidance concerning the Phase 2 OraGrowtH210 Trial of LUM-201 in PGHD
-
Form SC 13D CVRx, Inc. Filed by: NEW ENTERPRISE ASSOCIATES 10 L P
-
Form SC 13D Monte Rosa Therapeutics, Filed by: New Enterprise Associates 17, L.P.
-
Form 4 CVRx, Inc. For: Jul 02 Filed by: NEW ENTERPRISE ASSOCIATES 10 L P
-
Form 4 Bright Health Group Inc. For: Jun 28 Filed by: New Enterprise Associates 15, L.P.